Physician profile
Pavan Malur
NPI 1306131867
$3,338.56
in general payments reported to CMS, 2019-2025
18 companies · $594 in 2025
The $594 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,497 · 2020: $258 · 2021: $68.89 · 2022: $320 · 2023: $208 · 2024: $393 · 2025: $594.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,194.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $640.31 | 2022-2025 | Assure Wcd |
| Novo Nordisk INC | $532.90 | 2019-2024 | Rybelsus, Ozempic |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $434.52 | 2019-2025 | Lifevest |
| Amgen INC. | $375.51 | 2019-2020 | |
| Amarin Pharma, INC. | $178.98 | 2019-2022 | |
| Abiomed | $152.93 | 2023 | Impella |
| Esperion Therapeutics, INC. | $124.98 | 2020 | |
| Astellas Pharma US INC | $124.93 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.20 | 2019 | |
| Medtronic Vascular, INC. | $100.82 | 2019 | |
| United Therapeutics Corporation | $98.19 | 2019 | |
| Cvrx, INC. | $95.56 | 2019 | |
| Lilly USA, LLC | $87.85 | 2019 | |
| Abbott Laboratories | $85.37 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.71 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $63.95 | 2024-2025 | |
| Pfizer INC. | $29.12 | 2025 | |
| Daiichi Sankyo INC. | $28.73 | 2025 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pavan Malur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.